Cargando...
Global Cognitive Scores Do Not Predict Outcome After Subthalamic Nucleus Deep Brain Stimulation
BACKGROUND: Presence of dementia is a contraindication for DBS treatment of Parkinson’s disease. Recent evidence suggests that borderline cognitive function, as measured with a common screening measure, the Mattis Dementia Rating Scale, has a negative impact on quality of life (QoL) after DBS of the...
Guardado en:
| Publicado en: | Mov Disord |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5964333/ https://ncbi.nlm.nih.gov/pubmed/26175227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26292 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|